Small molecule protein assembly modulators with pan-cancer therapeutic efficacy

Two structurally unrelated small molecule chemotypes, represented by compounds PAV-617 and PAV-951, with antiviral activity in cell culture against Mpox virus (formerly known as monkeypox virus) and human immunodeficiency virus (HIV) respectively, were studied for anti-cancer efficacy. Each exhibited apparent pan-cancer cytotoxicity with reasonable pharmacokinetics. Non-toxicity is demonstrated in a non-cancer cell line and in mice at doses achieving drug exposure at active concentrations. Anti-tumour properties of both chemotypes were validated in mouse xenografts against A549 human lung cancer and, for one of the chemotypes, against HT-29 colorectal cancer. The targets of these compounds are unconventional: each binds to a different transient, energy-dependent multi-protein complex. Treatment with these compounds alters the target multi-protein complexes in a manner that appears to remove a block, crucial for cancer survival and progression, on a homeostatic linkage between uncontrolled proliferation and apoptosis. These compounds provide starting points for development of novel, next-generation, non-toxic, pan-cancer therapeutics.

Authors

Institutions

Publication Details

Journal
Open Biology
Published
2024-12-01
DOI
https://doi.org/10.1098/rsob.240210
Citations
5
Primary Topic
Virus-based gene therapy research
Type
article
Field-Weighted Citation Impact
2.75

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Small molecule protein assembly modulators with pan-cancer therapeutic efficacy

Thomas W. Campi, Anuradha F. Lingappa, Olayemi Akintunde, Dennis Solas et al.
5 citations
Open Biology
Virus-based gene therapy research
2.75
article

Small molecule protein assembly modulators with pan-cancer therapeutic efficacy

Thomas W. Campi, Anuradha F. Lingappa, Olayemi Akintunde, Dennis Solas, Jaisri R. Lingappa, Brad Fabbri, Suguna Mallesh, Vishwanath R. Lingappa, Shao Feng Yu, Niloufar Ziari, Connie Ewald, Sanjeev K. Anand, Ayşegül Nalça, Andreas Müller‐Schiffmann, James L. Rubenstein, David William Andrews, Emma Petrouski, Anatoliy Kitaygorodskyy, Markus Froehlich, Maya Michon, Ming‐Chi Lu, Carsten Korth, Dharma Prasad, Jonathan C. Reed, Debendranath Dey, Yessica Plata Fernández, Phuong Uyen Le, Jim Jung‐Ching Lin, Emily Aston, Erin Samueli
article en
5 citations

Abstract

Two structurally unrelated small molecule chemotypes, represented by compounds PAV-617 and PAV-951, with antiviral activity in cell culture against Mpox virus (formerly known as monkeypox virus) and human immunodeficiency virus (HIV) respectively, were studied for anti-cancer efficacy. Each exhibited apparent pan-cancer cytotoxicity with reasonable pharmacokinetics. Non-toxicity is demonstrated in a non-cancer cell line and in mice at doses achieving drug exposure at active concentrations. Anti-tumour properties of both chemotypes were validated in mouse xenografts against A549 human lung cancer and, for one of the chemotypes, against HT-29 colorectal cancer. The targets of these compounds are unconventional: each binds to a different transient, energy-dependent multi-protein complex. Treatment with these compounds alters the target multi-protein complexes in a manner that appears to remove a block, crucial for cancer survival and progression, on a homeostatic linkage between uncontrolled proliferation and apoptosis. These compounds provide starting points for development of novel, next-generation, non-toxic, pan-cancer therapeutics.

Open BiologyVol. 14(12)
University of California, San Francisco (US), University of Washington (US), United States Army Medical Research Institute of Infectious Diseases (US), Sunnybrook Hospital (CA), Sunnybrook Research Institute, Heinrich Heine University Düsseldorf (DE)
Leukemia and Lymphoma Society, Leukemia and Lymphoma Society of Canada, National Institutes of Health, Canadian Institutes of Health Research, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 9%
Virus-based gene therapy research
2.75
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.